{
    "Trade/Device Name(s)": [
        "Etest\u00ae Moxifloxacin"
    ],
    "Submitter Information": "BIOM\u00c9RIEUX",
    "510(k) Number": "K093604",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class III",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "July 16, 2010",
    "Summary Letter Received Date": "July 20, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Moxifloxacin"
    ],
    "Specimen Type(s)": [
        "Microorganisms on agar"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Minimum Inhibitory Concentration (MIC) determination"
    ],
    "Methodologies": [
        "Predefined antibiotic gradient on agar",
        "Overnight incubation"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Etest\u00ae Moxifloxacin antimicrobial susceptibility test for MIC determination of various bacteria",
    "Indications for Use Summary": "For MIC determinations of moxifloxacin at 0.002-32 \u03bcg/mL against aerobic and fastidious bacteria, including anaerobes, N. gonorrhoeae, S. pneumoniae, Streptococcus and Haemophilus species using agar-based testing",
    "fda_folder": "Microbiology"
}